\n<\/p>\n
JEFFERSON CITY, Mo. — <\/span>Delays could be in store for a proposed $7.25 billion settlement covering thousands of claims that the maker of Roundup weedkiller failed to warn people the product could cause cancer. <\/p>\n An attorney opposed to the settlement filed paperwork Friday to move the case to federal court instead of a Missouri court, where people face a June 4 deadline to opt out of the settlement. The dispute about who should preside over the proposed settlement could disrupt its deadlines and delay a resolution about whether it should be approved.<\/p>\n The legal wrangling over the settlement is playing out as the U.S. Supreme Court<\/a> weighs a case that could block thousands of lawsuits filed in state courts against agrochemical-maker Bayer, which added Roundup to its portfolio<\/a> when it acquired Missouri-based Monsanto in 2018. Bayer contends the state-level claims that it failed to warn of cancer risks should be forbidden because it followed federal labeling standards that don’t require a warning. <\/p>\n Germany-based Bayer also disputes the assertion that Roundup\u2019s key ingredient, glyphosate, can cause non-Hodgkin lymphoma.<\/p>\n The Environmental Protection Agency has determined that it\u2019s not likely to be carcinogenic<\/a> to humans when used as directed. But plaintiffs point to a 2015 decision by the World Health Organization\u2019s International Agency for Research on Cancer, which classified the chemical as \u201cprobably carcinogenic.\u201d<\/p>\n The case before the Supreme Court was filed on behalf John Durnell<\/a>, who says he developed non-Hodgkin lymphoma after more than 20 years of spraying Roundup on a community garden in St. Louis. Durnell is not covered by the proposed class-action settlement. But his attorney, Ashley Keller, filed objections opting out of the settlement on behalf of several other clients before also filing a document to shift the settlement case to federal court. <\/p>\n \u201cThis is a huge settlement that is extinguishing the rights of tens of thousands of cancer victims,” Keller said Friday. \u201cIt was rushed in to state court.\u201d <\/p>\n The move to federal court is sure to face opposition. <\/p>\n Attorney Christopher Seeger, who is proposed as a claimants\u2019 representative in the settlement, denounced the court shift as \u201ca baseless delay tactic that should be promptly denied.\u201d<\/p>\n A statement from Bayer said the move \u201chas no merit,\u201d and it would work to keep the proceedings in state court. <\/p>\n